Overlapping sirolimus-eluting stents: Intravascular ultrasound analysis frok the SIRIUS trial  by Morino, Yoshihiro et al.
JACC March 19,2003 ABSTRACTS - Angiography & Interventional Cardiology 81A 
Conclusions: These results suggest that plaque CA may influence NI growth with EMS. 
However, NI growth suppression of DES does not appear to be affected by the presence 
or location of CA. 
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Background: Direct stenting (DS) was shown to reduce the vessel ~njuly and restenosis 
rate in animal models. DS did not translate into the reduction of events and restenosis in 
clinical practice when compared to conventional strategy with balloon predilatation (PD). 
The purpose of this study was to examine whether DS guided by intravascular ultrasound 
(IVUS) reduced further the restenosis and the events rate. 
IUS, a prospective, randomized, multicenter trial comparing SES vs. bare metal stent 
(BMS). Stent overlao was identified bv the visible double stent struts on IVUS cross sec- 
tlonal image. External elastic membrane (EEM) area. lumen area (LA), and stent area 
(SA) were obtained by analyzing the center of the overlapped stent segment. Neointimal 
area (NIA) was calculated es SA minus LA. 
Results: Out of 130 serial IVUS cases (BMS 54: SES 76), there were 30 stent overlap 
segments (overlap BMS 17: overlap SES 13) in 27 cases eligible for quantitative and 
qualitative analysis. There was one case of late incomplete apposition in overlap SES, 
which does not represent a statistically higher incidence compared to overlap BMS. As 
expected, neointimal proliferation was less in overlap SES than overlap BMS, but there 
were no significant effect on EEM. 
Conclusions: Excellent suppression of neointimal formation in SES was also observed 
in overlapped stent segment without compromising vessel dimension. 
Methods: We analyzed the in-hospital and l-year outcomes of patients who were 
treated with percutaneous coronary interventions and stem implantation when percuta- 
neous intervention was guided by IVUS. Only patients treated for single de nova lesions 
were included. 
overlap BMS overlap SES p-value 
(fl=l7) (n=13) 
Results: In 1386 patients, 251 (18.1%) were treated with direct stenting and 1135 
(71.9%) were treated with balloon predilatation. Pre- and post-procedure characteristics 
by angiography were similar in both groups. The reference lumen area by IVUS was 0.7 
* 3.1 mm’ in the DS group and 8.3 + 3.0 m&in the PD group (p=O.21). Post procedure 
minimal stent areas (7.55 + 2.53 mm2 in the DS group and 7.72 * 2.72 mm2 in the PD 
group, p=O.55) were similar in the two groups. Post-procedure non-Q-wave myocardial 
infarction occurred in 4.9% of the DS group and in 12.5% of the PD group (p=O.O05). At 
one-year follow-up, target leston revascularization rate was 4.9% in the DS group and 
14.8% in the PD group (p=O.OOS). Major cardiac event rate was 11.4% and 18.9% in the 
DS and PD groups, respectively (p=O.O16). Direct stenting strategy (OR=0.46, CI=O.25- 
0.65, p=O.O13) was independently correlated to lower risk for revascularization in multi- 
vanate analysis.Conclusion: Direct stenting assisted by intravascular ultrasound 
reduces post-procedural adverse events and the need for repeat revascularization at one 
year. 
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The aim of this study was to examine detailed morphologic characteristw of local bio- 
logic response after drug-eluting stent (sirolimus-eluting stents, SES) implantation com- 
pared with bare metal stents (BMS). 
Methods: In the SIRIUS trial, serial IVUS (baseline and E-months) studies in 130 (SES 
76; BMS 54) lesions were carefully reviewed for evidence of instent thrombus. persistent 
edge tears, or stent incomplete apposition (IA) by 3 independent I blinded analysts. IA 
was further classified Into 3 types: A) absolute (>l struts separated from the vessel wall 
with evidence of blood speckle behind the struts), B) branch associated, and C) inter- 
strut cavities (struts not clearly separated from the vessel but cavities observed between 
the struts). 
Results: Serial IVUS revealed no evidence of instent thrombue or persistent edge tears 
in either group. Among 21 Type-A IA segments observed at follow-up (SES 15 (20%): 
BMS 6 (1 l%), p=ns). 6 BMS and 6 SES segments had IA at baseline (persistent IA). 
Type-B was frequently observed in both groups. However, all jailed branches remained 
patent at follow-up. There was a higher incidence of Type-C in SES than BMS (12% YS 
2%, pco.05). 
Conclusions: In this trial, Implantation of SES was not associated with late instent 
thrombus, persistent edge tears, or late branch occlusion. Morphologic characteristics of 
IA appeared to be different between drug-eluting stems and conventional BMS. Further 
studies will be needed to clarify the significance of these observatlons. 
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Background: Excellent suppression of neointimal hyperplasia after sirolimus-eluting 
stent (SES) implantation has been previously reported. The late effect of SES stent over- 
lapping on neointimal formation and vessel dimensions, however, has not been westi- 
gated. 
Background: To evaluate the focal impact of the pre-intervention “critical segment” on 
neointimal hyperplasia after stent implantation. 
Methods & Results: Serial (pre, post-stem and B-months follow-up) volumetric IVUS 
analysis was performed in 66 lesions treated with single stent implantation (ACS Multi- 
link, 15”” in length). Within the stented segment, a pre-intervention ‘“critical segment” 
was identified as the segment with lumen area (LA) less than 4 mr$. The remaining seg- 
ment(s) were defined es ‘“non-critical”. Average stent @A), LA, plaque (PA) and intimal 
areas (IA) were calculated to normalize with respect to different segment lengths, and 
percent IA was calculated to standardize SA. At pre-intervention. mean critical segment 
length was 7.06i2.76 mm. Immediately post stewing, baseline SA was smaller 
(8.26*1.96 vs.. 6.62 tl.66 “d/mm, p=O.OOl) and PA was greater (8.65+2.40 vs. 
6.04e2.26 mr!i?mm, p=O.O03) in the critical segment compared to the non-critical seg- 
ment(s). At 6-months, both IA (2.92+1.36 vs. 2.62el.25 mm3/mm, p=O.O13) and percent 
IA (36 vs. 31%, p=O.o002) were greater in critical than in non-critical segment(s). 
Because of potential impact of residual plaque burden or vessel stretch during the base- 
line procedure on intimal hyperplasia. correlation of IA and post-stem PA or periproce- 
dural VA change were examined. However, no correlation between IA and residual PA or 
VA change was observed either !n critical or non-critical segment(s) or combination of 
both. 
Conclusions: Within the stent, greater intimal hyperplasia developed I” the critical seg- 
ment compared to non-critical segment(s), without correlation with residual plaque bur- 
den or vessel stretch. These observations that the biology of restenosis is different in the 
critical segment may have an implication for the dosing/distribution of antirestenotic ther- 
apies. 
